294 related articles for article (PubMed ID: 17410192)
41. Single step immunophenotyping of acute leukemias not classifiable by standard morphology and cytochemistry: a practical approach.
Raimondi R; Pellizzari G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):66-72. PubMed ID: 8039763
[TBL] [Abstract][Full Text] [Related]
42. OMIP-010: a new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples.
Preijers FW; Huys E; Moshaver B
Cytometry A; 2012 Jun; 81(6):453-5. PubMed ID: 22532446
[No Abstract] [Full Text] [Related]
43. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
[TBL] [Abstract][Full Text] [Related]
44. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
45. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
Zwick D; Cooley L; Hetherington M
Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
[TBL] [Abstract][Full Text] [Related]
46. [Monoclonal antibodies in diagnosis of acute leukemias].
Krawczyńska A; Robak T
Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
[TBL] [Abstract][Full Text] [Related]
47. [New findings in the diagnosis of minimal residual disease in acute leukemia with emphasis on flow cytometry].
Vosková D; Váleková L; Kubisz P
Vnitr Lek; 1997 May; 43(5):332-6. PubMed ID: 9601859
[TBL] [Abstract][Full Text] [Related]
48. Acute leukemias of ambiguous origin.
Porwit A; Béné MC
Am J Clin Pathol; 2015 Sep; 144(3):361-76. PubMed ID: 26276768
[TBL] [Abstract][Full Text] [Related]
49. Immunophenotyping by Multiparameter Flow Cytometry.
Chen W; Luu HS
Methods Mol Biol; 2017; 1633():51-73. PubMed ID: 28735480
[TBL] [Abstract][Full Text] [Related]
50. Applicability of a single 5 color cytoplasmic markers tube as primary panel for immunophenotyping of acute leukemia: A Gujarat Cancer and Research Institute experience.
Parikh BP; Patel SP; Raiya BN; Vora HH; Jetly DH
Indian J Cancer; 2016; 53(3):349-352. PubMed ID: 28244454
[TBL] [Abstract][Full Text] [Related]
51. Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.
Reiter M; Diem M; Schumich A; Maurer-Granofszky M; Karawajew L; Rossi JG; Ratei R; Groeneveld-Krentz S; Sajaroff EO; Suhendra S; Kampel M; Dworzak MN;
Cytometry A; 2019 Sep; 95(9):966-975. PubMed ID: 31282025
[TBL] [Abstract][Full Text] [Related]
52. Flow cytometry in the diagnosis of acute leukemia.
Weir EG; Borowitz MJ
Semin Hematol; 2001 Apr; 38(2):124-38. PubMed ID: 11309694
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometry immunophenotyping in integrated diagnostics of patients with newly diagnosed cytopenia: one tube 10-color 14-antibody screening panel and 3-tube extensive panel for detection of MDS-related features.
Porwit A; Rajab A
Int J Lab Hematol; 2015 May; 37 Suppl 1():133-43. PubMed ID: 25976971
[TBL] [Abstract][Full Text] [Related]
54. [The application of 4-color fluorescence labeling antibodies and its significance in immunophenotyping for leukemia by flow cytometer].
Liu YR; Yu H; Chang Y; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):423-7. PubMed ID: 12513741
[TBL] [Abstract][Full Text] [Related]
55. A new automated flow cytometry data analysis approach for the diagnostic screening of neoplastic B-cell disorders in peripheral blood samples with absolute lymphocytosis.
Costa ES; Arroyo ME; Pedreira CE; García-Marcos MA; Tabernero MD; Almeida J; Orfao A
Leukemia; 2006 Jul; 20(7):1221-30. PubMed ID: 16728986
[TBL] [Abstract][Full Text] [Related]
56. Cytochemical staining and flow cytometry methods applied to the diagnosis of acute leukemia in the pediatric population: an assessment of relative usefulness.
Mhawech P; Buffone GJ; Khan SP; Gresik MV
J Pediatr Hematol Oncol; 2001 Feb; 23(2):89-92. PubMed ID: 11216712
[TBL] [Abstract][Full Text] [Related]
57. Gating strategy for immunophenotyping of leukemia and lymphoma.
Sun T; Sangaline R; Ryder J; Gibbens K; Rollo C; Stewart S; Rajagopalan C
Am J Clin Pathol; 1997 Aug; 108(2):152-7. PubMed ID: 9260755
[TBL] [Abstract][Full Text] [Related]
58. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
Dworzak MN; Buldini B; Gaipa G; Ratei R; Hrusak O; Luria D; Rosenthal E; Bourquin JP; Sartor M; Schumich A; Karawajew L; Mejstrikova E; Maglia O; Mann G; Ludwig WD; Biondi A; Schrappe M; Basso G;
Cytometry B Clin Cytom; 2018 Jan; 94(1):82-93. PubMed ID: 28187514
[TBL] [Abstract][Full Text] [Related]
59. Application of CD45/SSC gating multiparameter flow cytometry in the classification of acute leukemia--an analysis of 139 cases.
Li W; Chen Z; Liu Z; Zou P
J Tongji Med Univ; 2001; 21(3):209-11. PubMed ID: 12539578
[TBL] [Abstract][Full Text] [Related]
60. Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
Peters JM; Ansari MQ
Arch Pathol Lab Med; 2011 Jan; 135(1):44-54. PubMed ID: 21204710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
